These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 4556545)

  • 21. [Prostate carcinoma: an immuno-cryothermic answer].
    Gonder MJ; Soanes WS; Ablin RJ
    Z Urol Nephrol; 1970 Jun; 63(6):467-70. PubMed ID: 4097963
    [No Abstract]   [Full Text] [Related]  

  • 22. Letter: Antiepithelial antibodies: a possible clue to malignant neoplasms.
    Ablin RJ; Bystryn JC
    Arch Dermatol; 1974 Jun; 109(6):911-2. PubMed ID: 4133778
    [No Abstract]   [Full Text] [Related]  

  • 23. [Serum antibody levels of cytomegalovirus, herpes simplex type I and adenovirus in patients with benign or malignant prostatic neoplasms].
    Peker AF; Erkan I; Ozen HA; Ustaçelebi S; Ozdemir T
    Mikrobiyol Bul; 1986 Jul; 20(3):165-75. PubMed ID: 2436029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of the search for specific prostatic antigens in fixed specimens].
    Stouffs M; Wilmus JP; Couvreur Y; Dossogne M
    Acta Urol Belg; 1984; 52(4):588-92. PubMed ID: 6083718
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostatic origin of metastases: immunoperoxidase localization of prostate-specific antigen.
    Ghazizadeh M; Kagawa S; Maebayashi K; Izumi K; Kurokawa K
    Urol Int; 1984; 39(1):9-12. PubMed ID: 6203202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Specific antigens in human tumor cells].
    Pavliuchenkova RP; Korosteleva VS; Kosiakov PN
    Vopr Onkol; 1970; 16(6):38-44. PubMed ID: 4925690
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of an antibody that can detect the Kai1/CD82 murine metastasis suppressor.
    Custer MC; Risinger JI; Hoover S; Simpson RM; Patterson T; Barrett JC
    Prostate; 2006 May; 66(6):567-77. PubMed ID: 16372335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunochemical studies of prostatic acid phosphatase.
    Choe BK; Pontes EJ; McDonald I; Rose NR
    Cancer Treat Rep; 1977; 61(2):201-4. PubMed ID: 68823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study by immunofluorescence of the cells producing immunoglobulins in human pericancerous lymph nodes].
    Burtin P; Loisillier F; Buffe D; Guillerm M; Gluckman E
    Bull Soc Chim Biol (Paris); 1968 Sep; 50(5):1129-35. PubMed ID: 4177698
    [No Abstract]   [Full Text] [Related]  

  • 30. [Value of the immunohistochemical detection of PSA in the diagnosis of carcinoma of the prostate].
    Escaf S; Isorna S; Riesgo I
    Arch Esp Urol; 1987; 40(9):627-31. PubMed ID: 2449870
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunology of prostatic carcinoma-an overview.
    Frost P; Rose NR; Choe BK
    Semin Oncol; 1976 Jun; 3(2):107-13. PubMed ID: 935881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum zinc and prostatic cancer].
    Maganto E; Gil A; Mateos JA; Mayayo T; Verdú F; Escudero A
    Actas Urol Esp; 1982; 6(6):347-52. PubMed ID: 7183180
    [No Abstract]   [Full Text] [Related]  

  • 33. Recurrent and metastatic malignant disease: immunological considerations.
    Carter RL
    Proc R Soc Med; 1974 Sep; 67(9):852-4. PubMed ID: 4610589
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunological surveillance and -globulin.
    Ablin RJ
    Isr J Med Sci; 1973 Apr; 9(4):480-3. PubMed ID: 4122703
    [No Abstract]   [Full Text] [Related]  

  • 35. Lymphocytotoxic antibodies in prostatic cancer.
    Ablin RJ; Baird WM
    JAMA; 1971 Jun; 216(12):2015. PubMed ID: 4103257
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytotoxic antibodies to allogenic lymphocytes in prostatic cancer.
    Ablin RJ; Baird WM
    JAMA; 1972 Jan; 219(1):87. PubMed ID: 5066595
    [No Abstract]   [Full Text] [Related]  

  • 37. Circulating antibody to prostate antigen in patients with prostate cancer.
    Chu TM; Kuriyama M; Johnson E; Papsidero LD; Killian CS; Murphy GP; Wang MC
    Transplant Proc; 1984 Apr; 16(2):481-5. PubMed ID: 6202027
    [No Abstract]   [Full Text] [Related]  

  • 38. [The influence of humoral immune mechanisms on metastasizing tumors in humans (author's transl)].
    Lewis MG; Phillips TM; Rowden G; Hammer C
    MMW Munch Med Wochenschr; 1977 Oct; 119(43):1393-6. PubMed ID: 412076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prostate-specific antigen as a prognostic parameter of treated prostate carcinoma--a reliable tumor marker?].
    Knönagel H; Gautschi K; Vonderschmitt DJ; Hauri D
    Helv Chir Acta; 1988 Jul; 55(3):333-5. PubMed ID: 2459081
    [No Abstract]   [Full Text] [Related]  

  • 40. [Value of the immunohistochemical detection of prostate-specific antigen in the diagnosis of metastasis of carcinoma of the prostate].
    Escaf S; Isorna S; Riesgo I
    Arch Esp Urol; 1987; 40(1):17-21. PubMed ID: 2437868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.